These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18571644)

  • 1. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.
    Abe M; Takiguchi Y; Ichimaru S; Kaji S; Tsuchiya K; Wada K
    Eur J Pharmacol; 2008 Jul; 589(1-3):215-9. PubMed ID: 18571644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivation.
    Li C; Gao Y; Tian J; Shen J; Xing Y; Liu Z
    J Ethnopharmacol; 2011 Jun; 135(3):620-5. PubMed ID: 21459139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
    Villegas I; Martín AR; Toma W; de la Lastra CA
    Eur J Pharmacol; 2004 Nov; 505(1-3):195-203. PubMed ID: 15556153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Zhang XJ; Xiong ZB; Tang AL; Ma H; Ma YD; Wu JG; Dong YG
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):156-61. PubMed ID: 19566839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury.
    Abe M; Takiguchi Y; Ichimaru S; Tsuchiya K; Wada K
    J Pharmacol Sci; 2008 Apr; 106(4):571-7. PubMed ID: 18385540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
    Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
    Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.
    Collino M; Aragno M; Mastrocola R; Gallicchio M; Rosa AC; Dianzani C; Danni O; Thiemermann C; Fantozzi R
    Eur J Pharmacol; 2006 Jan; 530(1-2):70-80. PubMed ID: 16386242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection with forsythoside B in rat myocardial ischemia-reperfusion injury: relation to inflammation response.
    Jiang WL; Fu FH; Xu BM; Tian JW; Zhu HB; Jian-Hou
    Phytomedicine; 2010 Jul; 17(8-9):635-9. PubMed ID: 19959348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
    Chen C; Xu S; Wang WX; Ding YM; Yu KH; Wang B; Chen XY
    Arch Med Res; 2009 Feb; 40(2):79-88. PubMed ID: 19237016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
    Liu X; Xie W; Liu P; Duan M; Jia Z; Li W; Xu J
    Life Sci; 2006 Apr; 78(19):2255-64. PubMed ID: 16336978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A; Yan X; Tong C; Li J
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.